{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T08:16:05Z","timestamp":1784448965312,"version":"3.55.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We studied patients diagnosed with aspergillosis based on positive bronchoalveolar lavage (BAL) Aspergillus galactomannan (GM) who had follow-up BAL sampling within 180 days. GM trend and clinical outcome were concordant in only 60% (30\/50). While useful for the initial diagnosis, BAL GM trending does not always correlate with treatment response.<\/jats:p>","DOI":"10.1093\/ofid\/ofae114","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T10:48:06Z","timestamp":1709290086000},"source":"Crossref","is-referenced-by-count":10,"title":["Serial Bronchoalveolar Lavage Fluid <i>Aspergillus<\/i> Galactomannan and Treatment Response in Invasive Pulmonary Aspergillosis"],"prefix":"10.1093","volume":"11","author":[{"given":"Daniel Z P","family":"Friedman","sequence":"first","affiliation":[{"name":"Section of Infectious Disease, Department of Medicine, Mayo Clinic , Rochester, Minnesota , USA"},{"name":"Section of Infectious Diseases and Public Health, University of Chicago , Chicago, Illinois , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elitza S","family":"Theel","sequence":"additional","affiliation":[{"name":"Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall C","family":"Walker","sequence":"additional","affiliation":[{"name":"Section of Infectious Disease, Department of Medicine, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holenarasipur R","family":"Vikram","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic , Phoenix, Arizona , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymund R","family":"Razonable","sequence":"additional","affiliation":[{"name":"Section of Infectious Disease, Department of Medicine, Mayo Clinic , Rochester, Minnesota , USA"},{"name":"William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6581-3956","authenticated-orcid":false,"given":"Paschalis","family":"Vergidis","sequence":"additional","affiliation":[{"name":"Section of Infectious Disease, Department of Medicine, Mayo Clinic , Rochester, Minnesota , USA"},{"name":"William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"key":"2024042607412176700_ofae114-B1","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"2015","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2024042607412176700_ofae114-B2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2024042607412176700_ofae114-B3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1128\/JCM.02281-09","article-title":"Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis","volume":"48","author":"Koo","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2024042607412176700_ofae114-B4","doi-asserted-by":"crossref","first-page":"e0129022","DOI":"10.1371\/journal.pone.0129022","article-title":"Correlation between circulating fungal biomarkers and clinical outcome in invasive aspergillosis","volume":"10","author":"Neofytos","year":"2015","journal-title":"PLoS One"},{"key":"2024042607412176700_ofae114-B5","first-page":"CD012399","article-title":"Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients","volume":"5","author":"de Heer","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2024042607412176700_ofae114-B6","volume-title":"Product Sheet","author":"Platelia\u2122 Aspergillus Ag","year":"2013"},{"key":"2024042607412176700_ofae114-B7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024042607412176700_ofae114-B8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2024042607412176700_ofae114-B9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/crj.13462","article-title":"What are the factors affecting the recovery rate of bronchoalveolar lavage fluid?","volume":"16","author":"Shikano","year":"2022","journal-title":"Clin Respir J"},{"issue":"Suppl 2","key":"2024042607412176700_ofae114-B10","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/cid\/ciaa1786","article-title":"Defining galactomannan positivity in the updated EORTC\/MSGERC consensus definitions of invasive fungal diseases","volume":"72","author":"Mercier","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024042607412176700_ofae114-B11","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1128\/JCM.06423-11","article-title":"Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity","volume":"50","author":"D\u2019Haese","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2024042607412176700_ofae114-B12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1473-3099(04)01045-X","article-title":"Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis","volume":"4","author":"Mennink-Kersten","year":"2004","journal-title":"Lancet Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae114\/56809849\/ofae114.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/4\/ofae114\/57124555\/ofae114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/4\/ofae114\/57124555\/ofae114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T07:41:33Z","timestamp":1714117293000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae114\/7616955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,3,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae114","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,3,1]]},"article-number":"ofae114"}}